Waters Corp's Acquisition Financing: $4 Billion Term Loan Secured for Reverse Morris Trust with BD SpinCo
WAT sits 43% above its 52-week low of $275.05.
Summary
Augusta SpinCo Corporation, a subsidiary of BD, secured a $4 billion term loan facility to finance a cash distribution to BD as part of its Reverse Morris Trust transaction with Waters Corporation, significantly increasing the combined entity's debt.
Key Events · M&A and Partnerships · WAT
-
$4 Billion Term Loan Secured
Augusta SpinCo Corporation, a subsidiary of BD, entered into a Term Loan Credit Agreement for up to $4 billion.
-
Financing for Reverse Morris Trust
The loan will finance a cash distribution to BD in connection with the pending combination of BD's Biosciences and Diagnostic Solutions business with Waters Corporation.
-
Loan Structure and Maturity
The facility includes a $3.5 billion Tranche 1 loan maturing in 364 days and a $500 million Tranche 2 loan maturing in two years.
-
Financial Covenants Established
Post-acquisition, the combined entity will be subject to a maximum Leverage Ratio of 3.50:1.00 (with a temporary increase to 4.25:1.00 after the acquisition) and an Interest Coverage Ratio of at least 3.50:1.00.
Analysis · WAT · Industrial Applications And Services
This filing details a critical financing step for Waters Corporation's pending Reverse Morris Trust transaction with BD's Biosciences and Diagnostic Solutions business. The $4 billion term loan, secured by Augusta SpinCo (the entity being spun off from BD and then merged with Waters), represents a substantial financial obligation for the combined company. The primary use of these funds is to make a significant cash distribution to BD, the seller, which will increase the debt burden on the combined entity's balance sheet. While securing such a large facility ensures the execution of the strategic transaction, the associated debt load and financial covenants will be a key area of focus for investors, potentially impacting future financial flexibility and earnings. The short-term nature of Tranche 1 (364 days) suggests a plan for refinancing this portion quickly.
How filings like this one have moved
In the 30 days to Sep 17, 2026, 35.7% of the 1179 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.44%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, WAT was trading at $393.68 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $23.4B. The 52-week trading range was $275.05 to $423.56. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.